These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 14596258)

  • 1. Injection drug use site sanctioned.
    AIDS Patient Care STDS; 2003 Sep; 17(9):489-90. PubMed ID: 14596258
    [No Abstract]   [Full Text] [Related]  

  • 2. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.
    Tyndall MW; Kerr T; Zhang R; King E; Montaner JG; Wood E
    Drug Alcohol Depend; 2006 Jul; 83(3):193-8. PubMed ID: 16356659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injection facilities needed to combat infection crisis, AIDS network says.
    Martens D
    CMAJ; 2002 May; 166(11):1455. PubMed ID: 12054420
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C virus seroprevalence: selected health care settings in Texas.
    Melville SK; Heseltine G; Delamater E; Gilani Z; Hendricks K; Suarez L
    Tex Med; 2006 Mar; 102(3):56-61. PubMed ID: 17115588
    [No Abstract]   [Full Text] [Related]  

  • 5. The Dr. Peter Centre. Harm reduction nursing.
    Wood RA; Zettel P; Stewart W
    Can Nurse; 2003 May; 99(5):20-4. PubMed ID: 12778610
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug users embrace Vancouver site.
    AIDS Patient Care STDS; 2004 Mar; 18(3):186. PubMed ID: 15112644
    [No Abstract]   [Full Text] [Related]  

  • 7. Safer injection facilities for injection drug users: the debate continues.
    de Vlaming S
    CMAJ; 2002 Feb; 166(4):419; author reply 422, 424-5. PubMed ID: 11873915
    [No Abstract]   [Full Text] [Related]  

  • 8. Street nursing.
    Gold F
    Am J Nurs; 2009 Jul; 109(7):28-32. PubMed ID: 19546637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for evaluating North America's first medically supervised safer-injecting facility.
    Wood E; Kerr T; Montaner JS; Strathdee SA; Wodak A; Hankins CA; Schechter MT; Tyndall MW
    Lancet Infect Dis; 2004 May; 4(5):301-6. PubMed ID: 15120347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical dermatologic and genital manifestations in drug addicts infected with HIV].
    Nguyen VU; Van M; Nguyen TT; Nguyen TM
    Sante; 1996; 6(2):71. PubMed ID: 8705126
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia.
    Lloyd-Smith E; Brodkin E; Wood E; Kerr T; Tyndall MW; Montaner JS; Hogg RS
    AIDS; 2006 Feb; 20(3):445-50. PubMed ID: 16439879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
    Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS
    Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV/AIDS in India. The needle and the damage done.
    Cohen J
    Science; 2004 Apr; 304(5670):509-12. PubMed ID: 15105472
    [No Abstract]   [Full Text] [Related]  

  • 14. Sociodemographic disparities in access to addiction treatment among a cohort of Vancouver injection drug users.
    Wood E; Li K; Palepu A; Marsh DC; Schechter MT; Hogg RS; Montaner JS; Kerr T
    Subst Use Misuse; 2005; 40(8):1153-67. PubMed ID: 16040375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
    Kerr T; Small W; Moore D; Wood E
    Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advocacy and activism. Supervised injection facilities.
    Gold F
    Can Nurse; 2003 Feb; 99(2):14-8. PubMed ID: 12656011
    [No Abstract]   [Full Text] [Related]  

  • 17. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India.
    Mahanta J; Medhi GK; Paranjape RS; Roy N; Kohli A; Akoijam BS; Dzuvichu B; Das HK; Goswami P; Thongamba G;
    AIDS; 2008 Dec; 22 Suppl 5():S59-68. PubMed ID: 19098480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyber outreach: ST/HIV education online.
    Sandstra IL; Gold F; Jones E; Harris P; Taylor D
    Can Nurse; 2008 Jun; 104(6):24-8, 30-1. PubMed ID: 18642498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injection site gets 16-month extension.
    Jones D
    CMAJ; 2006 Oct; 175(8):859. PubMed ID: 17030931
    [No Abstract]   [Full Text] [Related]  

  • 20. High prevalence of unprotected sex among Finnish HIV-positive and HIV-negative injecting drug users.
    Kivelä PS; Krol A; Partanen AL; Ristola MA
    Scand J Public Health; 2009 Jun; 37(4):357-63. PubMed ID: 19372233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.